vs
Side-by-side financial comparison of Scilex Holding Co (SCLX) and Xos, Inc. (XOS). Click either name above to swap in a different company.
Xos, Inc. is the larger business by last-quarter revenue ($5.2M vs $4.8M, roughly 1.1× Scilex Holding Co). Xos, Inc. runs the higher net margin — -186.8% vs -961.9%, a 775.1% gap on every dollar of revenue. On growth, Xos, Inc. posted the faster year-over-year revenue change (-54.5% vs -67.8%). Over the past eight quarters, Scilex Holding Co's revenue compounded faster (-33.6% CAGR vs -35.7%).
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
Xos, Inc. is an American manufacturer of commercial electric vehicles (EVs) and mobile EV chargers.
SCLX vs XOS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $5.2M |
| Net Profit | $-46.1M | $-9.8M |
| Gross Margin | 45.5% | -50.5% |
| Operating Margin | -2317.8% | -186.6% |
| Net Margin | -961.9% | -186.8% |
| Revenue YoY | -67.8% | -54.5% |
| Net Profit YoY | -613.7% | 48.6% |
| EPS (diluted) | $-4.63 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.8M | $5.2M | ||
| Q3 25 | $10.6M | $16.5M | ||
| Q2 25 | $9.9M | $18.4M | ||
| Q1 25 | $5.0M | $5.9M | ||
| Q4 24 | $14.9M | $11.5M | ||
| Q3 24 | $14.4M | $15.8M | ||
| Q2 24 | $16.4M | $15.5M | ||
| Q1 24 | $10.9M | $12.6M |
| Q4 25 | $-46.1M | $-9.8M | ||
| Q3 25 | $-257.8M | $2.1M | ||
| Q2 25 | $-44.0M | $-7.5M | ||
| Q1 25 | $-26.1M | $-10.2M | ||
| Q4 24 | $-6.5M | $-19.0M | ||
| Q3 24 | $-4.4M | $-10.5M | ||
| Q2 24 | $-37.6M | $-9.7M | ||
| Q1 24 | $-24.4M | $-11.0M |
| Q4 25 | 45.5% | -50.5% | ||
| Q3 25 | 68.5% | 15.3% | ||
| Q2 25 | 66.9% | 8.8% | ||
| Q1 25 | 72.3% | 20.6% | ||
| Q4 24 | 68.5% | -32.4% | ||
| Q3 24 | 73.9% | 18.1% | ||
| Q2 24 | 73.2% | 13.1% | ||
| Q1 24 | 64.7% | 22.1% |
| Q4 25 | -2317.8% | -186.6% | ||
| Q3 25 | -1766.2% | -42.4% | ||
| Q2 25 | -207.2% | -38.5% | ||
| Q1 25 | -557.5% | -157.7% | ||
| Q4 24 | -190.5% | -127.0% | ||
| Q3 24 | -138.0% | -61.4% | ||
| Q2 24 | -95.4% | -73.2% | ||
| Q1 24 | -179.0% | -81.1% |
| Q4 25 | -961.9% | -186.8% | ||
| Q3 25 | -2441.5% | 12.9% | ||
| Q2 25 | -445.1% | -40.8% | ||
| Q1 25 | -521.2% | -173.3% | ||
| Q4 24 | -43.4% | -165.4% | ||
| Q3 24 | -30.4% | -66.6% | ||
| Q2 24 | -229.6% | -62.2% | ||
| Q1 24 | -224.0% | -87.1% |
| Q4 25 | $-4.63 | $-0.76 | ||
| Q3 25 | $-22.17 | $0.22 | ||
| Q2 25 | $-7.42 | $-0.91 | ||
| Q1 25 | $-2.26 | $-1.26 | ||
| Q4 24 | $8.53 | $-2.34 | ||
| Q3 24 | $-0.58 | $-1.32 | ||
| Q2 24 | $-7.67 | $-1.23 | ||
| Q1 24 | $-8.33 | $-1.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $14.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-207.8M | $23.3M |
| Total Assets | $365.0M | $60.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | $14.0M | ||
| Q3 25 | $878.0K | $14.1M | ||
| Q2 25 | $4.1M | $8.8M | ||
| Q1 25 | $5.8M | $4.8M | ||
| Q4 24 | $3.3M | $11.0M | ||
| Q3 24 | $77.0K | $8.4M | ||
| Q2 24 | $6.9M | $19.7M | ||
| Q1 24 | $1.8M | $46.2M |
| Q4 25 | $-207.8M | $23.3M | ||
| Q3 25 | $-176.9M | $31.1M | ||
| Q2 25 | $-249.0M | $18.3M | ||
| Q1 25 | $-211.5M | $24.8M | ||
| Q4 24 | $-192.6M | $33.6M | ||
| Q3 24 | $-211.3M | $50.8M | ||
| Q2 24 | $-214.7M | $59.2M | ||
| Q1 24 | $-189.8M | $67.8M |
| Q4 25 | $365.0M | $60.4M | ||
| Q3 25 | $275.9M | $73.8M | ||
| Q2 25 | $83.8M | $80.3M | ||
| Q1 25 | $79.0M | $87.7M | ||
| Q4 24 | $93.0M | $98.3M | ||
| Q3 24 | $100.4M | $120.5M | ||
| Q2 24 | $104.5M | $123.4M | ||
| Q1 24 | $91.2M | $135.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-17.5M | $2.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-17.5M | $2.4M | ||
| Q3 25 | $8.2M | $3.1M | ||
| Q2 25 | $7.0M | $4.6M | ||
| Q1 25 | $6.0M | $-4.8M | ||
| Q4 24 | $2.5M | $3.3M | ||
| Q3 24 | $5.1M | $-11.5M | ||
| Q2 24 | $2.3M | $-26.0M | ||
| Q1 24 | $9.4M | $-14.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-26.1M | ||
| Q1 24 | — | $-14.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -73.9% | ||
| Q2 24 | — | -168.1% | ||
| Q1 24 | — | -115.7% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
